One of the risks in the bio pharmaceutical supply chain is having single sourced materials. In some cases, single sourcing cannot be helped, due to proprietary materials or custom formulations. However, with commodity chemicals like acetonitrile, it should be a simple process to put in place several alternative sources in the event of a supply interruption. In fact, companies that depended on the chemical acetonitrile in 2008 attempted to mitigate their risk by approving several supplier brand alternatives.
This case study will discuss:
- The background on the acetonitrile supply, including its role in the co-product relationship and its manufacturing locations
- Lessons learned from the 2008 acetonitrile shortage "perfect storm"
- Proactive actions to mitigate a similar supply chain risk from occurring